Impact of biologic therapy on cancer outcomes in patients with immune checkpoint inhibitor-induced bullous pemphigoid

J Am Acad Dermatol. 2023 Mar;88(3):670-671. doi: 10.1016/j.jaad.2022.06.1186. Epub 2022 Jun 30.

¹ Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
² Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
³ Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
⁴ Department of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts.
⁵ Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: [email protected].
⁶ Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address: [email protected].

No abstract available

Publication types